Results 121 to 130 of about 73,583 (263)

Cirrhosis-associated intracranial shunting lesions: illustrative case. [PDF]

J Neurosurg Case Lessons
Haver J, Morrison M, Madhani SI, Bartnik C, Mazaris P, Somji M.   +5 more
europepmc   +1 more source

Interactive Roles of Metabolic Dysfunction‐Associated Steatotic Liver Disease and Nutritional Status in the Prognosis of Patients With Hepatocellular Carcinoma After Surgical Resection

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The prognostic effect of concurrent metabolic dysfunction‐associated steatotic liver disease (MASLD) on outcomes for hepatocellular carcinoma (HCC) patients remains unclear. The Prognostic Nutritional Index (PNI) reflects nutritional and inflammatory status and is a well‐known prognostic factor.
Chun‐Ting Ho, Chien‐An Liu, Chia‐Jung Ho, Yi‐Chen Lin, Shin‐Yu Tsai, Hao‐Jan Lei, Shu‐Cheng Chou, Yi‐Hsiang Huang, Ming‐Chih Hou, Jaw‐Ching Wu, Chien‐Wei Su   +10 more
wiley   +1 more source

Accuracy of Surveys for Estimating Coverage for Hepatitis A and B Vaccinations in Adults. [PDF]

Prev Chronic Dis
Crane LA, Hurley LP, Daley MF, Beaty B, Rice JD, Homdayjanakul KJ, Lyons J, Black CL, Lu PJ, Singleton JA.   +9 more
europepmc   +1 more source

Cardiometabolic Biomarkers for Disease Severity Prediction in Metabolic Dysfunction‐Associated Steatotic Liver Disease

The Kaohsiung Journal of Medical Sciences, EarlyView.
ABSTRACT The impacts of cardiometabolic risk factors (CMRFs) and the biomarkers on disease severity in metabolic dysfunction‐associated steatotic liver disease (MASLD) remain elusive. Accordingly, a multicenter study by recruiting MASLD patients from a nationwide registry database was conducted with a total of 2882 MASLD patients (54.1% males, mean age 
Jee‐Fu Huang, Chi‐Yi Chen, Ming‐Jong Bair, Tzu‐Chun Lin, Ming‐Lun Yeh, Pei‐Chien Tsai, Yu‐Ju Wei, Chih‐Wen Wang, Po‐Chen Liang, Ming‐Yen Hsieh, Mei‐Hsuan Lee, Chia‐Yen Dai, Chung‐Feng Huang, Ming‐Lung Yu, Wan‐Long Chuang   +14 more
wiley   +1 more source

Serum immunoglobulin G levels in patients with cirrhosis due to autoimmune hepatitis or other etiologies. [PDF]

Eur J Gastroenterol Hepatol
Su Y, Wang Q, Sun X, Zhao X, Zhao X, Jia J, Shan S.   +6 more
europepmc   +1 more source

Prevalence, Clinical Profiles, Disease Severity, and Patient Outcomes of Alcoholic Liver Disease in a Tertiary Care Hospital of Nepal. [PDF]

Health Sci Rep
Joshi B, Challa U, Aayush, Hernandez R, Devkota K, Yadav P, Dominguez RJR, Jawad A, Mateen MA, Dirani NA.   +9 more
europepmc   +1 more source

Temporal trends in U.S. mortality from liver cirrhosis and sepsis: A 25-year retrospective analysis (1999-2023). [PDF]

Medicine (Baltimore)
Faheem MSB, Sultan L, Zeeshan N, Sakarwala AS, Waheed A, Siddiqui SA, Hassan ST, Khan MI.   +7 more
europepmc   +1 more source

Clinical Outcomes and Non-Invasive Testing in Metabolic Dysfunction-Associated Steatohepatitis With Cirrhosis: A Systematic Review. [PDF]

Liver Int
Hagström H, Hellmund C, Lazarus JV, Ota R, Rinella ME, Sebastiani G, Tefos F, Younossi ZM, Noureddin M.   +8 more
europepmc   +1 more source

Endoscopic Treatment for Esophagogastric Variceal Bleeding in Patients With Acute‐on‐Chronic Liver Failure: An Observational Study

Portal Hypertension &Cirrhosis, EarlyView.
In patients with acute‐on‐chronic liver failure (ACLF), esophagogastric variceal bleeding (EGVB) represents a critical complication associated with high short‐term mortality. This study evaluated the efficacy of endoscopic treatment in this specific population and identified prognostic factors associated with 6‐week rebleeding and mortality.
Yanan Sun, Peng Li, Shibin Zhang, Yuening Zhang, Chunlei Fan, Ajuan Zeng, Yanna Liu, Huiguo Ding   +7 more
wiley   +1 more source

Unexpected hepatic lymphangiography during transcatheter arterial chemoembolization in a patient with hepatocellular carcinoma: a case report. [PDF]

Radiol Case Rep
Mori T, Takaki H, Yamada Y, Narita R, Asayama Y.   +4 more
europepmc   +1 more source